• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2',5'-寡聚腺苷酸合成酶 1 通过抑制 PAR 化来抑制 DNA 损伤诱导的细胞死亡。

Suppressing PARylation by 2',5'-oligoadenylate synthetase 1 inhibits DNA damage-induced cell death.

机构信息

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Department of Psychiatry, Case Western Reserve University, Cleveland, OH, USA.

出版信息

EMBO J. 2020 Jun 2;39(11):e101573. doi: 10.15252/embj.2019101573. Epub 2020 Apr 23.

DOI:10.15252/embj.2019101573
PMID:32323871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7265237/
Abstract

High expression of 2',5'-oligoadenylate synthetase 1 (OAS1), which adds AMP residues in 2',5' linkage to a variety of substrates, is observed in many cancers as a part of the interferon-related DNA damage resistance signature (IRDS). Poly(ADP-ribose) (PAR) is rapidly synthesized from NAD at sites of DNA damage to facilitate repair, but excessive PAR synthesis due to extensive DNA damage results in cell death by energy depletion and/or activation of PAR-dependent programmed cell death pathways. We find that OAS1 adds AMP residues in 2',5' linkage to PAR, inhibiting its synthesis in vitro and reducing its accumulation in cells. Increased OAS1 expression substantially improves cell viability following DNA-damaging treatments that stimulate PAR synthesis during DNA repair. We conclude that high expression of OAS1 in cancer cells promotes their ability to survive DNA damage by attenuating PAR synthesis and thus preventing cell death.

摘要

2',5'-寡聚腺苷酸合成酶 1(OAS1)的高表达,它将 AMP 残基添加到各种底物的 2',5' 连接中,是许多癌症中干扰素相关 DNA 损伤抵抗特征(IRDS)的一部分。聚(ADP-核糖)(PAR)在 DNA 损伤部位从 NAD 迅速合成,以促进修复,但由于广泛的 DNA 损伤导致的过多 PAR 合成会导致细胞死亡,这是由于能量耗竭和/或激活 PAR 依赖性程序性细胞死亡途径所致。我们发现 OAS1 将 AMP 残基添加到 PAR 的 2',5' 连接中,在体外抑制其合成并减少其在细胞中的积累。在 DNA 修复过程中刺激 PAR 合成的 DNA 损伤处理后,OAS1 表达增加可显著提高细胞活力。我们的结论是,癌细胞中 OAS1 的高表达通过减弱 PAR 合成从而防止细胞死亡来促进其在 DNA 损伤后存活的能力。

相似文献

1
Suppressing PARylation by 2',5'-oligoadenylate synthetase 1 inhibits DNA damage-induced cell death.2',5'-寡聚腺苷酸合成酶 1 通过抑制 PAR 化来抑制 DNA 损伤诱导的细胞死亡。
EMBO J. 2020 Jun 2;39(11):e101573. doi: 10.15252/embj.2019101573. Epub 2020 Apr 23.
2
PARPing for balance in the homeostasis of poly(ADP-ribosyl)ation.PARP 酶在聚(ADP-核糖)化平衡中的作用。
Semin Cell Dev Biol. 2017 Mar;63:81-91. doi: 10.1016/j.semcdb.2016.09.011. Epub 2016 Sep 21.
3
Functional differences in the promoters of the interferon-inducible (2'-5')A oligoadenylate synthetase and 6-16 genes in interferon-resistant Daudi cells.干扰素抗性Daudi细胞中干扰素诱导的(2'-5')A寡腺苷酸合成酶和6-16基因启动子的功能差异
Eur J Biochem. 1994 Jan 15;219(1-2):547-53. doi: 10.1111/j.1432-1033.1994.tb19970.x.
4
The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers.PARP1 的神秘功能:从 PAR 化酶活性到 PAR 阅读蛋白。
Cells. 2019 Dec 12;8(12):1625. doi: 10.3390/cells8121625.
5
[Regulation of human fibrolastic 2',5'-oligoadenylate synthetase gene activity in cytomegalovirus infected fibroblast cells].[巨细胞病毒感染的成纤维细胞中人类2',5'-寡腺苷酸合成酶基因活性的调控]
Vopr Virusol. 2007 Jan-Feb;52(1):28-36.
6
Transcriptional induction of the p69 isoform of 2',5'-oligoadenylate synthetase by interferon-beta and interferon-gamma involves three regulatory elements and interferon-stimulated gene factor 3.干扰素-β和干扰素-γ对2',5'-寡腺苷酸合成酶p69亚型的转录诱导涉及三个调控元件和干扰素刺激基因因子3。
Exp Cell Res. 1999 Jan 10;246(1):138-47. doi: 10.1006/excr.1998.4296.
7
Gene structure of the murine 2'-5'-oligoadenylate synthetase family.小鼠2'-5'-寡腺苷酸合成酶家族的基因结构。
Cell Mol Life Sci. 2002 Jul;59(7):1212-22. doi: 10.1007/s00018-002-8499-2.
8
Regulation of 2',5'-oligoadenylate synthetase gene expression by interferons and platelet-derived growth factor.干扰素和血小板衍生生长因子对2',5'-寡腺苷酸合成酶基因表达的调控
Mol Cell Biol. 1989 Mar;9(3):1060-8. doi: 10.1128/mcb.9.3.1060-1068.1989.
9
Transcriptional activation of human (2'-5')oligoadenylate synthetase gene expression by the phorbol ester 12-O-tetradecanoyl-phorbol 13-acetate in type-I-interferon-treated HL-60 and HeLa cells.佛波酯12 - O -十四烷酰佛波醇13 - 乙酸酯在I型干扰素处理的HL - 60和HeLa细胞中对人(2'-5')寡腺苷酸合成酶基因表达的转录激活作用
Eur J Biochem. 1992 Jul 1;207(1):297-304. doi: 10.1111/j.1432-1033.1992.tb17050.x.
10
Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.聚(ADP-核糖)化由 PARP1 介导:反应机制和调节蛋白。
Nucleic Acids Res. 2019 May 7;47(8):3811-3827. doi: 10.1093/nar/gkz120.

引用本文的文献

1
KIF26B and CREB3L1 Derived from Immunoscore Could Inhibit the Progression of Ovarian Cancer.免疫评分衍生的 KIF26B 和 CREB3L1 可抑制卵巢癌的进展。
J Immunol Res. 2024 Feb 13;2024:4817924. doi: 10.1155/2024/4817924. eCollection 2024.
2
Multi-omics analysis reveals interferon-stimulated gene OAS1 as a prognostic and immunological biomarker in pan-cancer.多组学分析揭示干扰素刺激基因 OAS1 可作为泛癌的预后和免疫生物标志物。
Front Immunol. 2023 Oct 20;14:1249731. doi: 10.3389/fimmu.2023.1249731. eCollection 2023.
3
How cancer cells make and respond to interferon-I.癌细胞如何产生和应对干扰素-I。
Trends Cancer. 2023 Jan;9(1):83-92. doi: 10.1016/j.trecan.2022.09.003. Epub 2022 Oct 8.
4
Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis.基于免疫基因分析构建和验证与膀胱尿路上皮癌相关的基因特征。
BMC Cancer. 2022 Aug 27;22(1):926. doi: 10.1186/s12885-022-09794-9.
5
Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer.OAS1过表达与胰腺癌预后不良相关。
Front Oncol. 2022 Jul 11;12:944194. doi: 10.3389/fonc.2022.944194. eCollection 2022.
6
Single B Cell Gene Co-Expression Networks Implicated in Prognosis, Proliferation, and Therapeutic Responses in Non-Small Cell Lung Cancer Bulk Tumors.非小细胞肺癌大块肿瘤中与预后、增殖及治疗反应相关的单B细胞基因共表达网络
Cancers (Basel). 2022 Jun 25;14(13):3123. doi: 10.3390/cancers14133123.
7
Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer.靶向MUC1-C可抑制三阴性乳腺癌中胞质核苷酸受体和STING的慢性激活。
Cancers (Basel). 2022 May 24;14(11):2580. doi: 10.3390/cancers14112580.
8
A Prognostic Model for Predicting Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Bladder Urothelial Carcinoma.一种预测膀胱尿路上皮癌肿瘤突变负荷和肿瘤浸润免疫细胞的预后模型。
Front Genet. 2022 Feb 18;13:708003. doi: 10.3389/fgene.2022.708003. eCollection 2022.
9
PD-L1 sustains chronic, cancer cell-intrinsic responses to type I interferon, enhancing resistance to DNA damage.PD-L1 维持慢性、肿瘤细胞内在的对 I 型干扰素的反应,增强对 DNA 损伤的抵抗力。
Proc Natl Acad Sci U S A. 2021 Nov 23;118(47). doi: 10.1073/pnas.2112258118.
10
Programmed Non-Apoptotic Cell Death in Hereditary Retinal Degeneration: Crosstalk between cGMP-Dependent Pathways and PARthanatos?遗传性视网膜变性中的程序性非细胞凋亡性细胞死亡:cGMP 依赖性途径与 PARthanatos 的串扰?
Int J Mol Sci. 2021 Sep 29;22(19):10567. doi: 10.3390/ijms221910567.

本文引用的文献

1
Characteristics of Human OAS1 Isoform Proteins.人 OAS1 同工型蛋白的特性。
Viruses. 2020 Jan 29;12(2):152. doi: 10.3390/v12020152.
2
The Cellular Localization of the p42 and p46 Oligoadenylate Synthetase 1 Isoforms and Their Impact on Mitochondrial Respiration.p42 和 p46 寡聚腺苷酸合成酶 1 同工型的细胞定位及其对线粒体呼吸的影响。
Viruses. 2019 Dec 4;11(12):1122. doi: 10.3390/v11121122.
3
Emerging roles of eraser enzymes in the dynamic control of protein ADP-ribosylation.新兴的橡皮擦酶在蛋白质 ADP-核糖基化的动态调控中的作用。
Nat Commun. 2019 Mar 12;10(1):1182. doi: 10.1038/s41467-019-08859-x.
4
OAS-RNase L innate immune pathway mediates the cytotoxicity of a DNA-demethylating drug.OAS-RNase L 先天免疫途径介导 DNA 去甲基化药物的细胞毒性。
Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):5071-5076. doi: 10.1073/pnas.1815071116. Epub 2019 Feb 27.
5
ELTA: Enzymatic Labeling of Terminal ADP-Ribose.ELTA:末端 ADP-核糖基的酶标记。
Mol Cell. 2019 Feb 21;73(4):845-856.e5. doi: 10.1016/j.molcel.2018.12.022. Epub 2019 Jan 31.
6
The multifaceted roles of PARP1 in DNA repair and chromatin remodelling.聚(ADP - 核糖)聚合酶1(PARP1)在DNA修复和染色质重塑中的多方面作用。
Nat Rev Mol Cell Biol. 2017 Oct;18(10):610-621. doi: 10.1038/nrm.2017.53. Epub 2017 Jul 5.
7
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.聚腺苷二磷酸核糖聚合酶抑制剂在非肿瘤性疾病治疗中的再利用机会。
Br J Pharmacol. 2018 Jan;175(2):192-222. doi: 10.1111/bph.13748. Epub 2017 Mar 26.
8
PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes.聚(ADP-核糖)聚合酶与ADP-核糖基化:将分子功能与生物学结果相联系的最新进展
Genes Dev. 2017 Jan 15;31(2):101-126. doi: 10.1101/gad.291518.116.
9
Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair.异柠檬酸脱氢酶1(IDH1)突变型胶质瘤因聚(ADP-核糖)聚合酶1(PARP1)介导的DNA修复受损而产生的化学敏感性。
Cancer Res. 2017 Apr 1;77(7):1709-1718. doi: 10.1158/0008-5472.CAN-16-2773. Epub 2017 Feb 15.
10
Endogenous DNA Damage as a Source of Genomic Instability in Cancer.内源性DNA损伤作为癌症基因组不稳定的一个来源。
Cell. 2017 Feb 9;168(4):644-656. doi: 10.1016/j.cell.2017.01.002.